SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-97-001383
Filing Date
1997-03-27
Accepted
1997-03-27 00:00:00
Documents
7
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 REPORT FOR YEAR ENDED 12/31/96 10-K405 162010
2 EMPLOYMENT AGREEMENT W/ KURT C. GUNTER EX-10.28 24411
3 CONSULTING AGREEMENT W/ PETER WIRTH EX-10.29 15634
4 COMPUTATION OF EARNINGS PER SHARE EX-11.1 1796
5 CONSENT OF ERNST & YOUNG, LLP EX-23.1 675
6 FINANCIAL DATA SCHEDULE EX-27.1 2057
7 IMPORTANT FACTORS RE: FORWARD LOOKING STATEMENTS EX-99.1 30216
  Complete submission text file 0000950135-97-001383.txt   238843
Mailing Address
Business Address 195 ALBANY STREET CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21481 | Film No.: 97565830
SIC: 2836 Biological Products, (No Diagnostic Substances)